MAR 14, 2017 7:40 AM PDT

A New Way to Starve Cancer Cells

When medical professionals are targeting a patient’s cancer, the goal is first to eliminate the cancer and if that isn't possible  get the cancer to stop growing. The spread of cancer cells from one area of the body to another, a process called metastasis, is what increases the risk of death in cancer patients. While each form of cancer is different in how it spreads and each patient is different, researchers around the globe are furiously trying to figure out what causes some cancers to grow out of control, and what, if anything, can shut down that growth.
One of the factors in the growth of cancer is a bit of a double-edged sword. The amino acid glutamine is is somewhat of a conundrum. Having adequate amounts of it is beneficial to nitrogen balance, the gut microbiome and our immune system. It’s a positive in many ways for staying healthy. Conversely, it’s also known that cancer cells live for glutamine. It’s known to be a strong catalyst in the grown of tumors. Bascially, there is no part of cancer growth and metabolism that isn’t spurred on by glutamine. It provides fuel in the form of nitrogen so cancer cells can replicate. It enhances protein and nucleotide synthesis and it can thwart the body’s own immune defense systems, resulting in a target rich environment in which cancer can flourish.
 
So, the simple answer would seem to find a way to starve the cancer cells of glutamine and stop their growth. As it turns out, that isn’t so simple. Researchers at the Centenary Institute in Sydney Australia have been working on the problem and may have a breakthrough on the way. Professor Jeff Holst is stated recently that his lab has made some significant strides in finding a way to mediate the glutamine factor in cancer metastasis. He explained, “We have known for 100 years that cancer cells take up nutrients and use them differently to normal cells but we haven’t been able to target that. Cancer cells have found ways to use glutamine to fuel their growth and they become addicted to it, they are so dependent on it, that if you take it away from the cells they die” In the course of this research, they have found new drugs that could potentially shut down the glutamine fueling of tumors, and leave healthy cells intact.
 
Holst, who is the Head of the Origins of Cancer Program at the Institute collaborated with colleagues at Sydney University and discovered an important role for a protein involved in the metabolism of certain cancer cells that is crucial for spurring the grown of cancer cells. In a press release about the a new drug that his team is working on Holst stated, “If we are able to specifically block the supply of nutrients to cancer cells by inhibiting the function of this protein, we can essentially ‘starve’ the cells and stop them from growing.” The team has also
been able to identify molecules that can stop this protein in its tracks and this information is now being developed to create new drugs.
 
The Institute and the researchers at the University of Sydney will be working with a privately held biotechnology company called MetabloQ Pty Ltd which is focused on translating the results of Associate Professor Holst’s research into drugs for testing in clinical trials. The video below talks more about the important work being done on the cancer-glutamine connection, check it out.
About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
SEP 14, 2020
Genetics & Genomics
Why Defects in One Gene Can Lead to Cancer in Kids
SEP 14, 2020
Why Defects in One Gene Can Lead to Cancer in Kids
While they may occur in adults, a rare, aggressive type of brain cancer called atypical teratoid rhabdoid tumors tend to ...
SEP 21, 2020
Cancer
The Protein ETV1 May Act as a Biomarker for Gastrointestinal Cancer
SEP 21, 2020
The Protein ETV1 May Act as a Biomarker for Gastrointestinal Cancer
Cancer is an incredibly diverse disease. It has many types and even sub-types, with a vast range of characteristics. Som ...
OCT 06, 2020
Drug Discovery & Development
New Immunotherapy Drug Effective Against Lung Cancer
OCT 06, 2020
New Immunotherapy Drug Effective Against Lung Cancer
A new study has confirmed that Tecentriq, an immunotherapy drug, improves survival rates among those with newly diagnose ...
OCT 26, 2020
Cancer
Attacking leukemia trojan horse style
OCT 26, 2020
Attacking leukemia trojan horse style
Researchers from the Max Planck Institute of Biochemistry have developed a new approach to targeting leukemic stem cells ...
OCT 30, 2020
Cancer
Fighting mesothelioma with curcumin
OCT 30, 2020
Fighting mesothelioma with curcumin
Research led by investigators at Flinders University in Australia is spearheading new developments in cancer prevention ...
NOV 03, 2020
Genetics & Genomics
One Eight Cancer Patients Also Carry Inherited Genetic Mutations
NOV 03, 2020
One Eight Cancer Patients Also Carry Inherited Genetic Mutations
Genetic sequencing technologies have rapidly advanced, reducing the time required to sequence the entire human genome fr ...
Loading Comments...